Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7
Xiangyu Jin(Jiangnan University), Yi Huang(Jiangxi University of Traditional Chinese Medicine)
Cited by 46
Related Papers
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
|Science Advances|2024|133